BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18981370)

  • 1. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases.
    Helzner EP; Scarmeas N; Cosentino S; Tang MX; Schupf N; Stern Y
    Neurology; 2008 Nov; 71(19):1489-95. PubMed ID: 18981370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Alzheimer disease to mortality in the United States.
    James BD; Leurgans SE; Hebert LE; Scherr PA; Yaffe K; Bennett DA
    Neurology; 2014 Mar; 82(12):1045-50. PubMed ID: 24598707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk for Alzheimer disease affects the brain throughout the lifespan.
    Linden DEJ
    Neurol Genet; 2020 Oct; 6(5):e516. PubMed ID: 33134514
    [No Abstract]   [Full Text] [Related]  

  • 4. The amyloid hypothesis of Alzheimer's disease at 25 years.
    Selkoe DJ; Hardy J
    EMBO Mol Med; 2016 Jun; 8(6):595-608. PubMed ID: 27025652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    McKhann GM; Knopman DS; Chertkow H; Hyman BT; Jack CR; Kawas CH; Klunk WE; Koroshetz WJ; Manly JJ; Mayeux R; Mohs RC; Morris JC; Rossor MN; Scheltens P; Carrillo MC; Thies B; Weintraub S; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):263-9. PubMed ID: 21514250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Alzheimer's Disease Therapy and Prevention Strategies.
    Graham WV; Bonito-Oliva A; Sakmar TP
    Annu Rev Med; 2017 Jan; 68():413-430. PubMed ID: 28099083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.
    Bachurin SO; Bovina EV; Ustyugov AA
    Med Res Rev; 2017 Sep; 37(5):1186-1225. PubMed ID: 28084618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.
    Gauthier S; Feldman HH; Schneider LS; Wilcock GK; Frisoni GB; Hardlund JH; Moebius HJ; Bentham P; Kook KA; Wischik DJ; Schelter BO; Davis CS; Staff RT; Bracoud L; Shamsi K; Storey JM; Harrington CR; Wischik CM
    Lancet; 2016 Dec; 388(10062):2873-2884. PubMed ID: 27863809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross sectional observational study on the societal costs of Alzheimer's disease.
    Mesterton J; Wimo A; By A; Langworth S; Winblad B; Jönsson L
    Curr Alzheimer Res; 2010 Jun; 7(4):358-67. PubMed ID: 19939223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cholinergic hypothesis of geriatric memory dysfunction.
    Bartus RT; Dean RL; Beer B; Lippa AS
    Science; 1982 Jul; 217(4558):408-14. PubMed ID: 7046051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2024 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2024 May; 20(5):3708-3821. PubMed ID: 38689398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors for survival in patients with Alzheimer's disease: a large comprehensive meta-analysis.
    Zheng X; Wang S; Huang J; Li C; Shang H
    Transl Psychiatry; 2024 Apr; 14(1):184. PubMed ID: 38600070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Disease: Models and Molecular Mechanisms Informing Disease and Treatments.
    Nystuen KL; McNamee SM; Akula M; Holton KM; DeAngelis MM; Haider NB
    Bioengineering (Basel); 2024 Jan; 11(1):. PubMed ID: 38247923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer's Coordinating Center Uniform Data Set.
    Crowell V; Reyes A; Zhou SQ; Vassilaki M; Gsteiger S; Gustavsson A
    BMC Neurol; 2023 Aug; 23(1):302. PubMed ID: 37580727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Comparative Effectiveness of Monotherapy and Combination Therapies: Impact of Angiotensin Receptor Blockers on the Onset of Alzheimer's Disease.
    Wang Y; Li M; Kazis LE; Xia W
    JAR Life; 2023; 12():35-45. PubMed ID: 37441415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia and electronic health record phenotypes: a scoping review of available phenotypes and opportunities for future research.
    Walling AM; Pevnick J; Bennett AV; Vydiswaran VGV; Ritchie CS
    J Am Med Inform Assoc; 2023 Jun; 30(7):1333-1348. PubMed ID: 37252836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation as a contributor to the mortality in patients with dementia: A nationwide cohort study.
    Chen YY; Lin YJ; Hsieh YC; Chien KL; Lin CH; Chung FP; Chen SA
    Front Cardiovasc Med; 2023; 10():1082795. PubMed ID: 37077740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and Predictors of In-Hospital Mortality among Older Patients with Dementia.
    De Matteis G; Burzo ML; Della Polla DA; Serra A; Russo A; Landi F; Gasbarrini A; Gambassi G; Franceschi F; Covino M
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.